Literature DB >> 11287191

Distinct domains mediate the early and late functions of the Drosophila ovarian tumor proteins.

L E Glenn1, L L Searles.   

Abstract

The Drosophila melanogaster ovarian tumor (otu) gene encodes two novel protein isoforms that are required at multiple stages of oogenesis. We have examined the activity of a set of C-terminal truncation Otu proteins as well as a GFP-tagged Otu (Otu-GFP). These experiments have shown that a putative Tudor domain in the central region of the large Otu isoform and a separate domain in the C-terminal region are required for regulation of cyst formation and oocyte maturation, respectively. We also present evidence that a portion of Otu co-fractionates with mRNA/protein complexes (mRNPs) and show that Otu-GFP associates with cytoplasmic aggregates at periphery of the nucleus at an intermediate stage of oogenesis. This study substantially clarifies the relationship between Otu structure and function and reveals new clues about interacting components.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11287191     DOI: 10.1016/s0925-4773(01)00314-8

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  3 in total

1.  Structural basis for ubiquitin recognition by the Otu1 ovarian tumor domain protein.

Authors:  Troy Eugene Messick; Nathaniel Scott Russell; Ayaka Jennifer Iwata; Kathryn Lorenz Sarachan; Ramin Shiekhattar; John R Shanks; Francisca E Reyes-Turcu; Keith D Wilkinson; Ronen Marmorstein
Journal:  J Biol Chem       Date:  2008-02-12       Impact factor: 5.157

2.  Evolutionary Loss of Activity in De-Ubiquitylating Enzymes of the OTU Family.

Authors:  Marcell Louis; Kay Hofmann; Meike Broemer
Journal:  PLoS One       Date:  2015-11-20       Impact factor: 3.240

3.  Prp22 and spliceosome components regulate chromatin dynamics in germ-line polyploid cells.

Authors:  Stephen Klusza; Amanda Novak; Shirelle Figueroa; William Palmer; Wu-Min Deng
Journal:  PLoS One       Date:  2013-11-07       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.